A potential for cumulative life course impairment is not completely considered in clinical practice, driving the ...

Affecting two to three percent of the global population, psoriasis should be viewed for what it is: a serious systemic ...

Psoriasis is a chronic, immune-mediated skin condition. It causes red, scaly, itchy, often inflamed patches. Because the ...

Your skin is in a constant state of reinvention. Every month, your body sheds and regenerates its entire outer layer—a ...

Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to ...

Ixekizumab was more effective for the treatment of mild to moderate psoriasis vs severe psoriasis at most time points through 52 weeks.

Eczema and psoriasis often worsen in winter due to cold air, low humidity, indoor heating and reduced sunlight.

North America and Western Europe — two wealthier regions of the world — reported the highest incidences and are projected to ...

Psoriasis causes your body to make new skin cells too quickly. These cells tend to pile up and form spots, bumps, and thick scaly patches called plaques that can be uncomfortable. Scientists think ...

Routine testing for latent tuberculosis infection is not required for patients receiving interleukin-17 or -23 inhibitors for psoriasis, according to an updated position statement. “When IL-17 and ...